Recently, Gloria Pharmaceuticals says its wholly-owned subsidiaries Shenzheng Gloria investment in ￥56 million to set up Gloria Gene Biological Technology (Shenzhen) Co., Ltd. with Tianjin Hengzhi. This company will began gene detection and gene big data service.

Gloria Pharmaceuticals says, With the development of precision medical, medical development will become more personalized, targeted, rely on big data and purpose for prevent disease. Gene sequencing technology will play an important role in the change time. And set up a gene company is conform to the development trend and national health policy.

Harbin Gloria Pharmaceuticals Co., Ltd. was founded in 2000, covering an area of more than 50,000 square meters.